List of Chapters/Sections(Table Of Content)
Table of Contents
Global Oncology Precision Medicine Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Oncology Precision Medicine Market by Value
2.2.1 Global Oncology Precision Medicine Revenue by Type
2.2.2 Global Oncology Precision Medicine Market by Value
2.3 Global Oncology Precision Medicine Market by Sales
2.3.1 Global Oncology Precision Medicine Sales by Type
2.3.2 Global Oncology Precision Medicine Market by Sales
3. The Major Driver of Oncology Precision Medicine Industry
3.1 Historical & Forecast Global Oncology Precision Medicine Sales and Revenue (2018-2028)
3.2 Largest Application for Oncology Precision Medicine (2018-2028)
3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Oncology Precision Medicine Market
4.1 Regional Market Size in Terms of Sales (2022 & 2028)
4.2 Regional Market Share in Terms of Revenue (2022 & 2028)
4.3 Concentration Ratio (CR5& CR10) of Oncology Precision Medicine Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Oncology Precision Medicine Sales (2018-2028)
5.1 Current and Estimated Sales Breakdown by Type (2018-2028)
5.2 Current and Estimated Sales Breakdown by Application (2018-2028)
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Oncology Precision Medicine Sales (2018-2028)
6.1 Current and Estimated Sales Breakdown by Type (2018-2028)
6.2 Current and Estimated Sales Breakdown by Application (2018-2028)
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Oncology Precision Medicine Sales (2018-2028)
7.1 Current and Estimated Sales Breakdown by Type (2018-2028)
7.2 Current and Estimated Sales Breakdown by Application (2018-2028)
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Oncology Precision Medicine Sales (2018-2028)
8.1 Current and Estimated Sales Breakdown by Type (2018-2028)
8.2 Current and Estimated Sales Breakdown by Application (2018-2028)
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Oncology Precision Medicine Sales (2018-2028)
9.1 Current and Estimated Sales Breakdown by Type (2018-2028)
9.2 Current and Estimated Sales Breakdown by Application (2018-2028)
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Oncology Precision Medicine Sales (2018-2028)
10.1 Current and Estimated Sales Breakdown by Type (2018-2028)
10.2 Current and Estimated Sales Breakdown by Application (2018-2028)
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Oncology Precision Medicine Sales (2018-2028)
11.1 Current and Estimated Sales Breakdown by Type (2018-2028)
11.2 Current and Estimated Sales Breakdown by Application (2018-2028)
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. South America Oncology Precision Medicine Sales (2018-2028)
12.1 Current and Estimated Sales Breakdown by Type (2018-2028)
12.2 Current and Estimated Sales Breakdown by Application (2018-2028)
12.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
12.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
13. Global Oncology Precision Medicine Average Price Trend
13.1 Market Price for Each Type of Oncology Precision Medicine in US (2018-2022)
13.2 Market Price for Each Type of Oncology Precision Medicine in Europe (2018-2022)
13.3 Market Price for Each Type of Oncology Precision Medicine in China (2018-2022)
13.4 Market Price for Each Type of Oncology Precision Medicine in Japan (2018-2022)
13.5 Market Price for Each Type of Oncology Precision Medicine in India (2018-2022)
13.6 Market Price for Each Type of Oncology Precision Medicine in Korea (2018-2022)
13.7 Market Price for Each Type of Oncology Precision Medicine in Southeast Asia (2018-2022)
13.8 Market Price for Each Type of Oncology Precision Medicine in South America (2018-2022)
14. Industrial Chain (Impact of COVID-19)
14.1 Oncology Precision Medicine Industrial Chain Analysis
14.2 Downstream
14.3 Impact of COVID-19
14.4 Post-pandemic Era
14.5 Technology Trends of Oncology Precision Medicine
15. Oncology Precision Medicine Competitive Landscape
15.1 Abbott Laboratories
15.1.1 Abbott Laboratories Company Profiles
15.1.2 Abbott Laboratories Product Introduction
15.1.3 Abbott Laboratories Oncology Precision Medicine Sales, Revenue (2018-2022)
15.1.4 Strategic initiatives
15.2 Agilent Technologies
15.2.1 Agilent Technologies Company Profiles
15.2.2 Agilent Technologies Product Introduction
15.2.3 Agilent Technologies Oncology Precision Medicine Sales, Revenue (2018-2022)
15.2.4 Strategic initiatives
15.3 Almac
15.3.1 Almac Company Profiles
15.3.2 Almac Product Introduction
15.3.3 Almac Oncology Precision Medicine Sales, Revenue (2018-2022)
15.3.4 Strategic initiatives
15.4 ANGLE plc
15.4.1 ANGLE plc Company Profiles
15.4.2 ANGLE plc Product Introduction
15.4.3 ANGLE plc Oncology Precision Medicine Sales, Revenue (2018-2022)
15.4.4 Strategic initiatives
15.5 Asuragen
15.5.1 Asuragen Company Profiles
15.5.2 Asuragen Product Introduction
15.5.3 Asuragen Oncology Precision Medicine Sales, Revenue (2018-2022)
15.5.4 Strategic initiatives
15.6 BGI Group
15.6.1 BGI Group Company Profiles
15.6.2 BGI Group Product Introduction
15.6.3 BGI Group Oncology Precision Medicine Sales, Revenue (2018-2022)
15.6.4 Strategic initiatives
15.7 Bio-Rad Laboratories
15.7.1 Bio-Rad Laboratories Company Profiles
15.7.2 Bio-Rad Laboratories Product Introduction
15.7.3 Bio-Rad Laboratories Oncology Precision Medicine Sales, Revenue (2018-2022)
15.7.4 Strategic initiatives
15.8 BioM?rieux
15.8.1 BioM?rieux Company Profiles
15.8.2 BioM?rieux Product Introduction
15.8.3 BioM?rieux Oncology Precision Medicine Sales, Revenue (2018-2022)
15.8.4 Strategic initiatives
15.9 Bristol Myers Squibb
15.9.1 Bristol Myers Squibb Company Profiles
15.9.2 Bristol Myers Squibb Product Introduction
15.9.3 Bristol Myers Squibb Oncology Precision Medicine Sales, Revenue (2018-2022)
15.9.4 Strategic initiatives
15.10 Roche Holding AG
15.10.1 Roche Holding AG Company Profiles
15.10.2 Roche Holding AG Product Introduction
15.10.3 Roche Holding AG Oncology Precision Medicine Sales, Revenue (2018-2022)
15.10.4 Strategic initiatives
15.11 Gilead Sciences
15.12 Illumina
15.13 Konica Minolta
15.14 LabCorp
15.15 MDxHealth
15.16 Myriad Genetics
15.17 Novartis
15.18 OPKO Health
15.19 Pacific Biosciences
15.20 Quest Diagnostics
15.21 Qiagen
16. Conclusion
17. Methodology and Data Source
